Artificial Intelligence in Diabetes Management Market - Global Industry Analysis

Artificial Intelligence in Diabetes Management Market By Technique ( Intelligent Data Analysis And Case-Based Reasoning), By Device (Insulin Delivery Devices, Glucose Monitoring Devices, And Diagnostic Devices) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 31-Mar-2022 Category: Pharmaceutical Report Format : PDF Pages: 160 Report Code: ZMR-3361 Status : Published

The global artificial intelligence in diabetes management market was at a market value of $93m in 2021 and is projected to reach over $600m by 2020. The global market is expected to register a CAGR of 33% during the forecast period.

Description

Industry Perspective:

The market report is an indispensable guide on growth factors, challenges, restraints, and opportunities in the global artificial intelligence in the diabetes management market. The competitive and geographical landscape is well elaborated in the report.

Artificial Intelligence in Diabetes Management Market: Overview

Artificial intelligence and machine learning have incredibly expanded the potential in the field of diabetes care. The AI-based management techniques in the field of diabetes mellitus are transforming rapidly with a goal to lower the prevalence of cases associated with diabetes 1 and 2. However, the application of artificial intelligence-based technology, particularly in self-managing diabetes, is crucial for enhancing the quality of life, boosting metabolic control, and for timely intervention for the patient population. Additionally, data-driven decisions help better manage diabetes.

COVID-19 Impact:

The outbreak of the Covid-19 pandemic has created a public health emergency that affected almost every sector globally. The pandemic has posed long-term effects on the global artificial intelligence in the diabetes management market as the government all across the globe announced worldwide lockdowns. The global market has witnessed a mixed impact of the Covid-19 pandemic. There was a significant spike in demand for artificial intelligence-based diabetes management because private healthcare was disrupted as a result of increasing covid cases. On the other hand, supply chain logistics were disrupted due to the ban on transportation and movement, which has left a negative impact on the global market. However, the post-pandemic landscape is likely to foster development opportunities in the global market in the forthcoming years.

Artificial Intelligence in Diabetes Management Market: Growth Drivers

Growing diabetes cases will drive the growth of the global market

The growing cases of diabetes all around the globe is one of the primary reasons fueling the growth of global artificial intelligence in the diabetes management market. However, such an increasing rate of diabetes can be attributed to the sedentary lifestyle of people and rapid urbanization globally. Additionally, the growing funding from private and government organizations is fueling the research and development activities to develop advanced solutions in diabetes management will further boost the growth rate. Artificial intelligent applications have vast clinical potential in preventing diabetes and educating people regarding their lifestyle. It also guides users regarding their exercise regime, dietary habits, and insulin injection schedules. The growing morbidity and mortality cases in several regions due to diabetes are fostering the large-scale adoption of artificial intelligence in diabetes management.

Global Artificial Intelligence in Diabetes Management Market

Artificial Intelligence in Diabetes Management Market: Restraints

Lack of awareness among people is likely to restrain the growth of the global market.

Consumers are not aware of the innovative solutions available in the market for managing diabetes effectively. Additionally, many diabetes patients do not prefer monitoring their diabetes frequently, which is also likely to hamper the growth of the market.

Artificial Intelligence in Diabetes Management Market: Opportunities

Advancements in the field of artificial intelligence are likely to create new avenues in the global market.

The ongoing innovation and development activities in the field of artificial intelligence are likely to create new lucrative growth opportunities in the global artificial intelligence in the diabetes management market. Also, the integration of advanced technology with healthcare facilities will further expand the potential of the global market.

Artificial Intelligence in Diabetes Management Market: Challenges

Need for high investment is a huge challenge in the global market.

Research activities and clinical trials require high investments, which limits the scope of the global market. On the other hand, the end products are also expensive. Therefore, not many consumers are willing to go with smart solutions for diabetes management.

Artificial Intelligence in Diabetes Management Market: Segmentation

The global artificial intelligence in the diabetes management market can be segmented into technique, device, and region.

By technique, the market can be segmented into intelligent data analysis and case-based reasoning.

By device, the market can be segmented into insulin delivery devices, glucose monitoring devices, and diagnostic devices.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Recent Developments

  • Medtronic, in November 2020, introduced CGM integrated smart insulin pen in the market. The company said that the launch of the product could be integrated with Guardian Connect CGM Data.
  • Tandem Diabetes Care Inc, in January 2020, introduced slim X2 – the new version of T. It can effectively be integrated with Dexcom G6 CGM. Also, it is the first device that can deliver automatic correction boluses, which in turn will proliferate the firm’s portfolio.

Artificial Intelligence in Diabetes Management Market: Regional Landscape

North America holds the largest share in the global market.

North America accounts for the largest share of the global artificial intelligence in the diabetes management market due to the ongoing innovations in artificial intelligence-based services. Also, the growing awareness among consumers regarding the availability of smart devices for managing diabetes will further contribute to the growth of the regional market. However, the region is in the next stage of digitalization, and therefore, concepts like robotics, machine learning, big data, artificial intelligence, and the internet of things are expanding rapidly in different fields. Prominent market players are launching innovative products in the market to expand the market base, which is likely to further develop the regional market.

Asia Pacific to emerge as the fastest-growing region in the global market.

Asia Pacific is likely to grow significantly in the forthcoming years due to the presence of a large diabetes population base in the region.

Artificial Intelligence in Diabetes Management Market: Competitive Landscape

Some of the significant players in the global artificial intelligence in the diabetes management market include Vodafone Group Plc, Tidepool, IBM Corporation, Google Inc., Glooko Inc., Diabnext, and Apple Inc.

Global artificial intelligence in the diabetes management market is segmented as follows:

By Technique

  • Intelligent Data Analysis
  • Case-Based Reasoning

By Device

  • Insulin Delivery Devices
  • Glucose Monitoring Devices
  • Diagnostic Devices

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Artificial Intelligence in Diabetes Management Market, 2015 - 2024 (USD Million)
    • 2.2. Global Artificial Intelligence in Diabetes Management Market: Snapshot
  •  
  • Chapter 3. Artificial Intelligence in Diabetes Management - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Artificial Intelligence in Diabetes Management Market drivers: Impact analysis
      • 3.2.2. The benefit of Artificial Intelligence in Diabetes Management
      • 3.2.3. Increase of geriatric population
    • 3.3. Market Restraints
      • 3.3.1. High cost
      • 3.3.2. Lack of Awareness
    • 3.4. Opportunities
      • 3.4.1. Untapped Market
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Device type
      • 3.6.2. Market attractiveness analysis, by techniques type
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Artificial Intelligence in Diabetes Management Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Artificial Intelligence in Diabetes Management market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Patent Analysis
      • 4.2.4. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.5. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Artificial Intelligence in Diabetes Management Market - Device Type Segment Analysis
    • 5.1. Global Artificial Intelligence in Diabetes Management market: Device overview
      • 5.1.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Device, 2015 and 2024
      • 5.1.2. Glucose Monitoring Devices
        • 5.1.2.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Glucose Monitoring Devices, 2015 and 2024
      • 5.1.3. Diagnostic Devices
        • 5.1.3.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Diagnostic Devices, 2015 and 2024
      • 5.1.4. Insulin Delivery Devices
        • 5.1.4.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Insulin Delivery Devices, 2015 and 2024
      • 5.1.5. Other Devices
        • 5.1.5.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Other Devices, 2015 and 2024
  •  
  • Chapter 6. Global Artificial Intelligence in Diabetes Management Market - Techniques Type Segment Analysis
    • 6.1. Global Artificial Intelligence in Diabetes Management market: Techniques overview
      • 6.1.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Techniques, 2015 and 2024
      • 6.1.2. Case-based Reasoning
        • 6.1.2.1. Global Artificial Intelligence in Diabetes Management market revenue share, by
        • 6.1.2.2. Case-based Reasoning type, 2015 and 2024
      • 6.1.3. Intelligent Data Analysis
        • 6.1.3.1. Global Artificial Intelligence in Diabetes Management market revenue share, by Intelligent Data Analysis, 2015 and 2024
  •  
  • Chapter 7. Global Artificial Intelligence in Diabetes Management Market - Regional Segment Analysis
    • 7.1. Global Artificial Intelligence in Diabetes Management market: Regional overview
      • 7.1.1. Global Artificial Intelligence in Diabetes Management market revenue share, by region, 2015 and 2024
    • 7.2. North America
      • 7.2.1. North America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
      • 7.2.2. North America Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.2.3.2. U.S. Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.2.4. Rest of Asia Pacific
        • 7.2.4.1. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.2.4.2. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
      • 7.3.2. Europe Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.3.3. UK
        • 7.3.3.1. UK Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.3.3.2. UK Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.3.4.2. Germany Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.3.5.2. France Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.3.6.2. Rest of Europe Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
      • 7.4.2. Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.4.3. China
        • 7.4.3.1. China Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.4.3.2. China Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.4.4.2. Japan Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.4.5. India
        • 7.4.5.1. India Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.4.5.2. India Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.4.6.2. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
      • 7.5.2. Latin America Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.5.3.2. Brazil Artificial Intelligence in Diabetes Management market revenue, by Application, 2015 - 2024(USD Million)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
        • 7.5.4.2. Rest of Latin America Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 - 2024(USD Million)
      • 7.6.2. Middle East and Africa Artificial Intelligence in Diabetes Management market revenue, by Techniques 2015 - 2024(USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Apple Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Diabnext,
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Glooko Inc.,
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Google Inc.,
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. IBM Corporation,
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Tidepool
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Vodafone Group Plc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Artificial Intelligence in Diabetes Management market revenue, 2015 – 2024 (USD Million) 
4. Porter’s five forces analysis
5. Artificial Intelligence in Diabetes Management market attractiveness analysis, by Devices segment
6. Artificial Intelligence in Diabetes Management market attractiveness analysis, by Techniques segment
7. Artificial Intelligence in Diabetes Management: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2017 
9. Global Artificial Intelligence in Diabetes Management market revenue share by Devices, 2015 and 2023
a. Global Glucose Monitoring Devices Artificial Intelligence in Diabetes Management market, 2015 – 2024 (USD Million)
b. Global Diagnostic Devices Artificial Intelligence in Diabetes Management market, 2015 – 2024 (USD Million)
c. Global Insulin Delivery Devices Artificial Intelligence in Diabetes Management market, 2015 – 2024 (USD Million)
d. Global Other Devices Artificial Intelligence in Diabetes Management market, 2015 – 2024 (USD Million)
10. Global Artificial Intelligence in Diabetes Management market revenue share by Techniques, 2015 and 2023
a. Global Case-based Reasoning market, 2015 – 2024 (USD Million)
b. Global Intelligent Data Analysis market, 2015 – 2024 (USD Million)


Table Of Tables

List of Tables

1. Artificial Intelligence in Diabetes Management Market: Market snapshot                                                                                    
2. Drivers of global Artificial Intelligence in Diabetes Management market: Impact analysis 
3. Restraints of Artificial Intelligence in Diabetes Management market: Impact analysis  
4. North America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
5. North America Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
6. U.S. Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
7. U.S. Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
8. Rest of North America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
9. Rest of North America Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
10. Europe Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
11. Europe Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
12. UK Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
13. UK Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
14. Germany Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
15. Germany Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
16. France Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
17. France Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
18. Rest of Europe Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
19. Rest of Europe Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
20. Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
21. Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
22. China Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
23. China Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
24. India Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
25. India Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
26. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
27. Rest of Asia Pacific Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
28. Latin America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
29. Latin America Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
30. Brazil Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
31. Brazil Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
32. Rest of Latin America Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
33. Rest of Latin America Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)
34. Middle East and Africa Artificial Intelligence in Diabetes Management market revenue, by Devices, 2015 – 2024 (USD Million)
35. Middle East and Africa Artificial Intelligence in Diabetes Management market revenue, by Techniques, 2015 – 2024 (USD Million)

Methodology

Free Analysis

Diabetes is a metabolic disorder characterized by depletion of insulin in the human body due to lack of pancreatic activity. Asia Pacific region is the fastest growing region in terms of diabetes mellitus. Diabetes can be life-threatening if not controlled in time. Hence, diabetes can’t be cured and can only be controlled by various means like food/diet, exercises, and others. With the help of artificial intelligence, various hardware and software techniques are being introduced for controlling and managing diabetes.

Globally, the artificial intelligence in diabetes management market has seen an accelerated growth due to the continuously growing diabetic population across the world. In addition, torpid lifestyle, eating junk food, lack of exercise are some of the major factors driving the artificial intelligence in diabetes management market. Furthermore, increasing mobile phone users coupled with technological advancements in artificial intelligence software are other major drivers for the growth of artificial intelligence in diabetes management market. However, stringent rules and regulations hinder the growth of artificial intelligence in diabetes management market. Nonetheless, ongoing research and development in the field of technology of artificial intelligence may bring huge growth opportunities for the growth of the market within the forecast period.  

Global Artificial Intelligence in Diabetes Management Market

Based on device type, the global artificial intelligence in diabetes management market is classified into four types as diagnostic devices, glucose monitoring devices, insulin delivery devices, and other devices. Glucose monitoring devices accounted for the largest market share in terms of revenue in the year 2017. This growth is attributed to the increasing demand for medical devices due to low cost and better affordability. 

Based on region, the global artificial intelligence in diabetes management market is fragmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In terms of revenue share, North America is projected to retain the largest share of the global artificial intelligence in diabetes management market during the forecast period. Whereas, Europe accounted for the second largest market share in the year 2017. Asia Pacific is expected to grow with the fastest CAGR within the forecast period. Developing economies like China and India are the major regional markets of this region in artificial intelligence in diabetes management market. Also, increasing healthcare expenditure in this region is expected to bring huge growth opportunities in the artificial intelligence in diabetes management market.

The report covers company profiles and company market share, reimbursement policy of the key participants operating in the global artificial intelligence in diabetes management market. Some of the key players included in the report are Apple Inc., Diabnext, Glooko Inc., Google Inc., IBM Corporation, Tidepool, and Vodafone Group Plc.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The growing cases of diabetes all around the globe is one of the primary reasons fueling the growth of global artificial intelligence in the diabetes management market. However, such an increasing rate of diabetes can be attributed to the sedentary lifestyle of people and rapid urbanization globally. Additionally, the growing funding from private and government organizations is fueling the research and development activities to develop advanced solutions in diabetes management will further boost the growth rate.

Some of the significant players in the global artificial intelligence in the diabetes management market include Vodafone Group Plc, Tidepool, IBM Corporation, Google Inc., Glooko Inc., Diabnext, and Apple Inc.

 

North America accounts for the largest share of the global market due to the ongoing innovations in artificial intelligence-based services. Also, the growing awareness among consumers regarding the availability of smart devices for managing diabetes will further contribute to the growth of the regional market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed